← Lymphatic Malformation Variant Atlas
c.1624G>A NM_006218.3 PI3K-AKT transition, gain of function
| ISSVA subset | Allele fraction | Sources |
|---|---|---|
| LM | 0.5-23% | |
| GLA | 0.5-23% |
Bars show the reported allele-fraction range on a 0 to 50 percent axis.
Driver of the PI3K-AKT pathway. Repurposed drugs already used in the clinic for this pathway: alpelisib (PI3Kα inhibitor), sirolimus (mTOR inhibitor).
Mentioned in 1,868 publications indexed by Europe PMC.